On ECHEMI
Home > Drugs > Rifaximin Registered Holders
Rifaximin structure

Rifaximin structure

Rifaximin

Rifaximin(Xifaxan) is an orally administered, semi-synthetic, nonsystemic antibiotic derived from rifamycin SV with antibacterial activity.IC50 Value:Target: RNA polymerase; antibacterialRifaximin is a semisynthetic, rifamycin-based non-systemic antibiotic, meaning that very little of the drug will pass the gastrointestinal wall into the circulation as is common for other types of orally administered antibiotics. It is used in the treatment of traveler's diarrhea and hepatic encephalopat

Find 37 Related Holders

Southwest Pharmaceutical Co., Ltd.
China China

API Registration Country

API Active
  • Founded in:

    2015-01-08
  • Country:

    China China
  • Address:

    No. 21 Tianxing Bridge, Shapingba District, Chongqing
  • Tax NO.:

    915000003316906249
  • Registered Funds:

    490.146298 million yuan
  • Website:

  • Email:

CKD BIO CORP.
European Union European Union

API Registration Country

API Active
EUROAPI ITALY SRL
United States United States

API Registration Country

API Active
F.I.S.Fabbrica Italiana Sintetici S.p.A.
Japan Japan

API Registration Country

API Active
ZHEJIANG MEDICINE CO., LTD.
European Union European Union

API Registration Country

API Active
LUOHE CHIEF PHARMACEUTICAL CO., LTD.
European Union European Union

API Registration Country

API Active
Cosma S.p.A.
European Union European Union

API Registration Country

API Active
GRANULES INDIA LIMITED
European Union European Union

API Registration Country

API Active
Cambrex Profarmaco Milano S.r.l.
European Union European Union

API Registration Country

API Active
OPTIMUS DRUGS PRIVATE LIMITED
European Union European Union

API Registration Country

API Active
Recommended Suppliers of Rifaximin
View 81 Suppliers Request for Quotation
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.